Skip to main content
SpringerLink
Log in

Medical Therapy of Valvular Heart Disease

  • Chapter
  • First Online:
Valvular Heart Disease

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 1420 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bonow R, Carabello B, Chatterjee K, et al. ACC/AHA 2006 Guidelines for the Management of Patients with Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 2006;48(3):e1–148.

    Article  PubMed  Google Scholar 

  2. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006 Aug 15;114(7):e257–354.

    Google Scholar 

  3. Stulak JM, Sundt TM III, Dearani JA, Daly RC, Orsulak TA, Schaff HV. Ten-year experience with the Cox-maze procedure for atrial fibrillation: how do we define success? Ann Thorac Surg 2007 Apr;83(4):1319–24.

    Article  PubMed  Google Scholar 

  4. Salem DN, Stein PD, Al-Ahmad A, et al. Anti-thrombotic therapy in valvular heart disease-native and prosthetic. The seventh ACCP conference on anti-thrombotic and thrombolytic therapy. Chest 2004;126(suppl);457S–82S.

    Article  PubMed  CAS  Google Scholar 

  5. Smith SC, Feldman TE, Hirshfeld JW, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. Available at http://www.acc.org

  6. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective rndocarditis. guidelines from the American Heart Association. A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:1736–54.

    Google Scholar 

  7. WHO. Rheumatic fever and rheumatic heart disease: report of a WHO Expert Consultation, Geneva. 29 October–1 November, 2001.

    Google Scholar 

  8. Awan NA, DeMaria AN, Miller RR, et al. Beneficial effects of nitroprusside administration on left ventricular dysfunction and myocardial ischemia in severe aortic stenosis. Am Heart J 1981 Apr;101(4):386–94.

    Article  PubMed  CAS  Google Scholar 

  9. Khot UN, Novaro GM, Popovic ZB, et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 2003;348:1756–63.

    Article  PubMed  CAS  Google Scholar 

  10. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005 Jun 9;352(23):2389–97.

    Article  PubMed  CAS  Google Scholar 

  11. Moura LM, Ramos SF, Zamorano JL, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 2007 Feb 6;49(5):554–61.

    Article  PubMed  CAS  Google Scholar 

  12. Roseboro AB, Pedersen TR, Boman K et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008;359:1343–56.

    Article  Google Scholar 

  13. Nessim SJ, Richardson RM. Dialysis for thiocyanate intoxication: a case report and review of the literature. ASAIO J. 2006 Jul–Aug;52(4):479–81.

    Article  PubMed  Google Scholar 

  14. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). Available at http://www.nhlbi.nih.gov/guidelines/hypertension/

  15. Greenberg B, Massie B, Bristow JD, et al. Long-term vasodilator therapy of chronic aortic insufficiency. A randomized double-blinded, placebo-controlled clinical trial. Circulation 1988 Jul;78(1):92–103.

    PubMed  CAS  Google Scholar 

  16. Scognamiglio R, Fasoli G, Ponchia A, et al. Long-term nifedipine unloading therapy in asymptomatic patients with chronic severe aortic regurgitation. J Am Coll Cardiol 1990 Aug;16(2):424–9.

    Article  PubMed  CAS  Google Scholar 

  17. Scognamiglio R, Rahimtoola SH, Fasoli G, et al. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 1994 Sep 15;331(11):689–94.

    Article  PubMed  CAS  Google Scholar 

  18. Sondergaard L, Aldershvile J, Hildebrandt P, et al. Vasodilatation with felodipine in chronic asymptomatic aortic regurgitation. Am Heart J 2000 Apr;139(4):667–74.

    Article  PubMed  CAS  Google Scholar 

  19. Schon HR, Dorn R, Barthel P, et al. Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation. J Heart Valve Dis 1994 Sep;3(5):500–9.

    PubMed  CAS  Google Scholar 

  20. Lin M, Chiang HT, Lin SL, et al. Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy. J Am Coll Cardiol 1994 Oct;24(4):1046–53.

    Article  PubMed  CAS  Google Scholar 

  21. Evangelista A, Tornos P, Sambola A, et al. Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med 2005 Sep 29;353(13):1342–9.

    Article  PubMed  CAS  Google Scholar 

  22. Olesen KH. The natural history of 271 patients with mitral stenosis under medical treatment. Br Heart J 1962;24:349–57.

    Article  PubMed  CAS  Google Scholar 

  23. Melen-Mucha G, Lawnicka H, Kierszniewska-Stepien D, Komorowski J, Stepien H. The place of somatostatin analogs in the diagnosis and treatment of the neuoroendocrine glands tumors. Recent Pat Anticancer Drug Discov. 2006; 1(2):237–54.

    Google Scholar 

  24. The Task Force on Management of Valvular Heart Disease of the European Society of Cardiology. Guidelines on the management of valvular heart disease. Euro Heart J 2007;28:230–68.

    Google Scholar 

  25. Kulik A, Rubens FD, Wells PS, et al. Early postoperative anticoagulation after mechanical valve replacement: a systematic review. Ann Thorac Surg 2006 Feb;81(2):770–81.

    Article  PubMed  Google Scholar 

  26. Guidelines for the Diagnosis of Rheumatic Fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 1992 Oct 21;268(15):2069–73.

    Google Scholar 

  27. O’Donoghue M, Malhotra R, Baggish A, et al. Cardiology. In: Sabatine M, Ed. Pocket Medicine (3rd ed). Philadelphia, PA: Lippincott, Williams and Wilkins; 2007.

    Google Scholar 

  28. Goldsmith I, Turpie AGG, Lip GYH. ABC of antithrombotic therapy: valvular heart disease and prosthetic heart valves. BMJ 2002 Nov 23;325:1228–31.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA, USA

    Sahil A. Parikh MD & Patrick T. O’Gara MD

Authors
  1. Sahil A. Parikh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrick T. O’Gara MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Cardiovascular Medicine, Duke University Medical Center, Erwin Road, Durham, 27710-3504, U.S.A.

    Andrew Wang

  2. Division of Cardiovascular Medicine, Duke University Medical Center, Erwin Road, Durham, 27710-3504, U.S.A.

    Thomas M. Bashore

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Parikh, S.A., O’Gara, P.T. (2009). Medical Therapy of Valvular Heart Disease. In: Wang, A., Bashore, T. (eds) Valvular Heart Disease. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-411-7_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-411-7_16

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-982-6

  • Online ISBN: 978-1-59745-411-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation